Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.
Life Sci
; 291: 120260, 2022 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-34968466
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetic Nephropathies
/
Telmisartan
Limits:
Animals
Language:
En
Journal:
Life Sci
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: